Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
M
Medico Remedies Ltd
Score 63/100• Decent
Medico Remedies Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks. Caution is advised for investors.
Company’s Health80/100
Valuation 20/100 · PB 6.4852
Technical Avoid
1M 25.645% 6M -17.338% 1Y -1.234%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#151
View details ➜
M
Medico Intercontinental Ltd
Score 63/100• Decent
Medico Intercontinental Ltd shows potential but faces challenges in growth and profitability metrics.
Company’s Health64/100
Valuation 100/100 · PB 0.7141
Technical Avoid
1M -10.005% 6M -12.779% 1Y -31.14%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#152
View details ➜
I
Infinium Pharmachem Ltd
Score 63/100• Decent
Infinium Pharmachem Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health80/100
Valuation 40/100 · PB 3.1468
Technical Avoid
1M -3.26% 6M 5.219% 1Y -24.911%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#153
View details ➜
L
Laxmi Dental Ltd
Score 63/100• Decent
Laxmi Dental Ltd shows potential in a growing sector, but faces significant challenges in profitability and valuation metrics. Caution is advised.
Company’s Health72/100
Valuation 20/100 · PB 8.4353
Technical Avoid
1M 1.492% 6M -22.455% 1Y -41.822%
Confidence100%
Low leverage (D/E)No promoter pledge
#154
View details ➜
A
Asston Pharmaceuticals Ltd
Score 63/100• Decent
Asston Pharmaceuticals Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised due to execution risks.
Company’s Health91/100
Valuation 20/100 · PB 7.0923
Technical Avoid
1M -11% 6M -26.451% 1Y -26.451%
Confidence100%
No promoter pledgeHealthy profit margins
#155
View details ➜
N
Novateor Research Laboratories Ltd
Score 63/100• Decent
The stock shows some potential but faces significant risks and challenges that may hinder growth.
Company’s Health63/100
Valuation 80/100 · PB 1.5504
Technical Avoid
1M 2.662% 6M -35.561% 1Y -48.375%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#156
View details ➜
B
Bharat Immunologicals and Biologicals Corporation Ltd
Score 63/100• Decent
Bharat Immunologicals shows potential but faces significant challenges in growth and profitability metrics.
Company’s Health49/100
Valuation 80/100 · PB 1.0254
Technical Avoid
1M -5.429% 6M -8.15% 1Y -22.231%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#157
View details ➜
B
Balaxi Pharmaceuticals Ltd
Score 63/100• Decent
Balaxi Pharmaceuticals has potential but faces significant challenges in growth and profitability metrics.
Company’s Health87/100
Valuation 100/100 · PB 0.9999
Technical Avoid
1M -7.09% 6M -37.321% 1Y -55.136%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#158
View details ➜
B
Brawn Biotech Ltd
Score 62/100• Decent
Brawn Biotech Ltd shows potential in a growing sector but faces significant challenges in profitability and execution risks.
Company’s Health46/100
Valuation 80/100 · PB 1.9243
Technical Avoid
1M 3.8% 6M 18.082% 1Y 3.755%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#159
View details ➜
V
Veerhealth Care Ltd
Score 58/100• Decent
Veerhealth Care Ltd shows potential in a growing sector, but faces significant challenges in profitability and governance that could hinder future performance.
Company’s Health55/100
Valuation 80/100 · PB 1.6443
Technical Avoid
1M -0.055% 6M 22.617% 1Y -14.104%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#160
View details ➜
G
Genomic Valley Biotech Ltd
Score 58/100• Decent
Genomic Valley Biotech Ltd shows potential in a growing sector, but faces significant challenges in profitability and valuation metrics.
Company’s Health45/100
Valuation 60/100 · PB 2.6585
Technical Avoid
1M -21.39% 6M -50.362% 1Y -66.667%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#161
View details ➜
S
Sanjivani Paranteral Ltd
Score 58/100• Decent
Sanjivani Paranteral Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
Company’s Health86/100
Valuation 20/100 · PB 6.2531
Technical Avoid
1M -13.295% 6M -18.836% 1Y -30.126%
Confidence100%
Low leverage (D/E)No promoter pledge
#162
View details ➜
A
Achyut Healthcare Ltd
Score 58/100• Decent
Achyut Healthcare Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
Company’s Health70/100
Valuation 40/100 · PB 4.6434
Technical Momentum
1M 13.296% 6M 86.154% 1Y 67.723%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#163
View details ➜
A
Aakaar Medical Technologies Ltd
Score 58/100• Decent
Aakaar Medical Technologies Ltd shows potential in a growing sector, but faces significant challenges in growth consistency and profitability metrics.
Company’s Health81/100
Valuation 20/100 · PB 5.1315
Technical Avoid
1M -7.692% 6M 17.895% 1Y 17.895%
Confidence100%
No promoter pledgeDecent revenue growth
#164
View details ➜
T
TTK Healthcare Ltd
Score 57/100• Decent
TTK Healthcare Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
Company’s Health80/100
Valuation 80/100 · PB 1.4973
Technical Avoid
1M -6.014% 6M -8.918% 1Y -32.022%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#165
View details ➜
Showing 151 to 165 of 301 (21 Pages)